Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes.

about

Moving beyond subcutaneous insulin: the application of adjunctive therapies to the treatment of type 1 diabetes.

Item

http://www.wikidata.org/entity/Q42008289

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Moving beyond subcutaneous ins ...... treatment of type 1 diabetes.

@en

Moving beyond subcutaneous ins ...... treatment of type 1 diabetes.

@nl

type

Item

label

Moving beyond subcutaneous ins ...... treatment of type 1 diabetes.

@en

Moving beyond subcutaneous ins ...... treatment of type 1 diabetes.

@nl

prefLabel

Moving beyond subcutaneous ins ...... treatment of type 1 diabetes.

@en

Moving beyond subcutaneous ins ...... treatment of type 1 diabetes.

@nl

P1476

Moving beyond subcutaneous ins ...... e treatment of type 1 diabetes

@en

P2093

Kathleen H Ang

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

The Physiology of Glucagon-like Peptide 1

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes

Feasibility of Long-Term Closed-Loop Control: A Multicenter 6-Month Trial of 24/7 Automated Insulin Delivery.

Evaluating the Experience of Children With Type 1 Diabetes and Their Parents Taking Part in an Artificial Pancreas Clinical Trial Over Multiple Days in a Diabetes Camp Setting.

Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe.

Multinational Home Use of Closed-Loop Control Is Safe and Effective.

Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion.

Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp.

P304

1113-1131

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17425247.2017.1360862

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer L Sherr

P577

2017-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28774208

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes